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Abstract
Background: Inflammatory cytokines are linked to obesity-related insulin resistance and may predict type 2 diabetes 
independently of obesity. We previously reported that a majority of a cohort of 73 non-diabetic women with normal 
plasma (p-)glucose with Amerindian heritage in Lima, Peru, during a 5-year period increased both body weight and p-
glucose levels, yet p-insulin was unaltered. A high proportion of palmitoleic acid (16:1n-7) in serum (s) and systolic 
blood pressure (SBP) were independent predictors of high p-glucose. Whether cytokines also contributed is, however, 
not known.
Methods: During 5 years we prospectively investigated the relation between changed concentrations of p-tumor 
necrosis factor (TNF)-α, p-interleukin (IL)-6 and circulating insulin and glucose in relation to the natural variation of 
body weight. Study variables included anthropometric measurements, p-insulin, TNF-α, IL-6, SBP and the proportion of 
16:1n-7 in s-fatty acid composition.
Results: Weight and waist differences correlated negatively to the difference in p-TNF-α but positively to differences in 
p-IL-6 and p-insulin, whereas the increase of p-glucose from baseline to follow-up did not correlate with changes in 
levels of the two cytokines. In multiple regression analysis changes of TNF-α and insulin contributed independently to 
the variance in weight. P-insulin at baseline and weight change were determinants of fasting p-insulin at follow-up. 
Multiple regression analysis revealed that weight change (t-value = - 2.42; P = 0.018) and waist change (t-value = 2.41; P 
= 0.019) together with S-16:1n-7 (p < 0.0001) and SBP (p = 0.0005) at baseline were significant predictors of p-glucose 
at follow-up.
Conclusion: Our prospective study of Amerindian women revealed disassociations between changes in p-TNF-α and 
p-IL-6 in relation to variation in body weight. A high proportion of s-16:1n-7, SBP at baseline together with weight and 
waist changes were independent predictors of p-glucose at follow-up. The exact role of the opposite effects and 
clinical impact of p-TNF-α and p-IL-6 on loss and gain of body weight and indirectly on the development of glucose 
intolerance is not known.
Background
Sedentary socioeconomically marginalized women with
an Amerindian heritage living in a northern suburb of
Lima, the capital of Peru, were in a previous study charac-
terized by normal fasting plasma (p-)glucose levels, but
high insulin levels [1,2]. A follow-up after five years
revealed that the majority of the women along with
increased body weight and fat mass had developed higher
fasting p-glucose values possibly concomitant with insuf-
ficient insulin secretion. The proportion of palmitoleic
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acid (16:1n-7) in serum (s) and systolic blood pressure
were strong independent determinants of p-glucose con-
centration 5 years later [3].
In this study, we examined whether cytokines may con-
tribute to this metabolic state as there is a growing body
of evidence indicating that obesity may be associated to
chronic activation of the innate immune system [4],
resulting in progressive impairment of glucose tolerance
a n d  t y p e  2  d i a b e t e s  [ 5 ] .  H o w e v e r ,  e l e v a t e d  l e v e l s  o f
inflammatory markers may also predict type 2 diabetes
independently of obesity [6], and future weight-gain [7].
These results support the view that elevated levels of
inflammatory markers occur early in the process, leading
to glucose intolerance with or without concomitant
weight gain. A possibility is therefore that cytokines, such
as interleukin (IL)-6 and tumor necrosis factor (TNF)-α,
contribute to the development of insulin resistance and
impaired islet function. This is, however, controversial
because in a cross-sectional study, neither p-TNF-α nor
p-IL-6 levels were independently associated with hepatic
or peripheral insulin action [8]. Nevertheless, in people
with type 2 diabetes, the circulating p- IL-6 concentration
is correlated with adipose tissue mass, rather than with
whole-body insulin sensitivity [9], suggesting that IL-6
may be a marker of obesity without any direct contribu-
tion to the development of insulin resistance.
Cytokines are, in many ways, involved in the regula-
tions of metabolism and food intake. TNF-α influences
energy homeostasis, has an anorexigenic effect on the
hypothalamus [10], and a role in the development of neo-
plastic anorexia [11]. High concentrations of TNF-α and
IL-6 are associated with lower muscle strength and
endurance [12]. Furthermore, higher levels of TNF-α are
associated with greater 5-year decline in thigh muscle
area and grip strength [13]. It is obvious that very small
alterations in metabolism or food intake can cause a
moderate weight decrease.
The present study sought to explore whether a change
of circulating TNF-α or IL-6 during follow-up of 5 years
in our material of Amerindian women [1-3] was associ-
ated with gain or loss of body weight, and whether it pre-
dicted fasting insulin and glucose concentrations.
Methods
Study participants
The original study [1] consisted of 182 Peruvian Amerin-
dian women living in a northern urban area of Lima. A
migration antecedent from indigenous Andean commu-
nities in Peru was identified in all participants. The age
range was 20-59 with a mean of 41 years. Fatty acid com-
position in serum was measured in 141 subjects. All of
these subjects had normal fasting p-glucose concentra-
tions. This subgroup was invited to participate in a new
survey [3] five years later. Seventy-nine subjects attended
the second investigation. P-glucose concentrations were
available from 73 subjects in both investigations. These
73 women did not differ significantly from the remaining
68 in baseline characteristics of p-concentrations of insu-
lin and glucose, s-palmitoleic acid (16:1n-7) or body
weight. None of the participants was taking cholesterol
lowering medication, was consuming a special diet, had
ongoing cardiovascular disease, or was pregnant.
Approval for the study had been given in 1998 and 1999
by the Ethics Committees of Lund University and San
Martin University Hospital in Lima. Furthermore, the fol-
low-up examination was separately approved by the Eth-
ics Committe of San Martin University Hospital. The
study was undertaken in accordance with the Helsinki
Declaration of 1975, as revised in 1983. Informed consent
was obtained from all subjects.
Study methods
The examinations took place in the morning after an
overnight fast at Alternativa, a center for social research
and popular education in the district of San Martin,
Lima.
Anthropometric measurements
Trained nurses measured weight, height and waist cir-
cumferences. Changes in the respective values were cal-
culated as measurement at follow-up subtracted from the
baseline value. Body mass index (BMI; in kg/m2) was cal-
culated according to the standard formula. Body fat mass
and the percentage fat mass in relation to body mass were
determined by measuring the resistance of the body to a
low-level electrical current (Biodynamic Model 310e;
Biodynamic Research Inc, Seattle, WA). Measurements
were performed with subjects lying on a couch for 5 min,
and the electrodes were placed on the dorsal surfaces of
the right hand and foot.
Measurement of p-insulin, glucose, TNF- α and IL-6
Serum or plasma was separated from venous blood and
stored within 1 hour at -20°C and then brought to Swe-
den for analysis. P-insulin was measured with double-
antibody radioimmunoassay techniques with the use of
guinea pig anti-human insulin antibodies and human
insulin as the standard (Linco Research, St Charles, MO,
USA). P-glucose was measured by using the glucose oxi-
dase procedure. For the indirect determination of insulin
sensitivity, the homeostasis model assessment of insulin
resistance (HOMA-IR) was calculated as follows [14]:
HOMA-IR = [fasting insulin (in pmol/L) x fasting glucose
(in mmol/L)/22,5]. P-TNF- α and p-IL-6 were measured
by ELISA using commercially available test kits
(Pharmingen, San Diego, CA, USA). Detection limits
were 0.12 pg/ml and 0.70 pg/ml [15], intraassay coeffi-Lindgärde et al. Diabetology & Metabolic Syndrome 2010, 2:38
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cients of variation (CV) were 8.8% and 4.4%, and interas-
say CV were 16.7% and 6.4%, respectively.
Lipid extraction and serum fatty acid measurements
The fatty acid composition of s-cholesteryl esters was
measured as previously described [16]. Serum was
extracted with a hexane-isopropanol solution, and cho-
lesteryl esters (only lipid esters that were measured at
baseline) were separated from the extract by thin-layer
chromatography before interesterification with acidic
methanol was performed. Free cholesterol that had been
liberated in the reaction was removed by aluminum oxide
to avoid contamination of the column. The composition
of methylated fatty acids was determined by gas chroma-
tography (25-m NB-351 silica capillary column) with a
flame ionization detector and helium as carrier gas. Every
25th sample was a serum control pool. The CV between
successive gas chromatography runs was 0.2-5%. The rel-
ative amount of fatty acid was expressed as a percentage
of the total amount of fatty acids reported.
Statistical analyses
Data are expressed as mean ± SD. The correlation coeffi-
cients between 2 variables were determined by Spearman
rank analysis. Differences between measurements at
baseline and at follow-up levels were analysed by use of
Wilcoxon signed rank tests (Table 1). Because p-concen-
trations of glucose, TNF-α, IL-6, and insulin values fol-
lowed a log-normal distribution, logarithmic
transformation was used for these variables. Multiple
regression analyses were undertaken to examine which
variables predicted alterations of weight and waist during
the observation period and p-glucose and insulin values
at follow-up. The selected variables were forced into the
model based on analysis (Table 2) and prior findings such
as 16:1-n7 and systolic blood pressure [3]. All statistical
analyses were conducted by using the statistical package
STATVIEW (version 5.0.1, for Macintosh; SAS Institute
Inc, Cary, NC).
Table 1: Indices of adiposity and metabolic markers at baseline survey and at follow-up 5 years later.
Baseline Follow - up
N7 3 7 3
Age (y) 40.8 ± 10.8
Body weight (kg) 60.0 ± 13.9 63.1 ± 15.0***
Waist (cm) 84.1 ± 12.5 91.3***
BMI (kg/m2) 25.9 ± 5.5 27.2***
Percentage fat mass (%) 35.2 ± 5.4 36.7 ± 5.1**
Fat mass kg 23.1 ± 8.1 23.7 ± 8.0**
P-glucose (mmol/L) 4.12 ± 0.45 5.01 ± 1.25***
Insulin (pmol/L) 80.9 ± 42.6 83.4 ± 62.9
HOMA -IR 15.2 ± 9.1 19.0 ± 15.5**
Interleukin-6 (pg/mL) 2.03 ± 2.49 1.89 ± 1.50
TNF-α(pg/mL) 4.43 ± 5.98 3.35 ± 3.85**
All values are means ± SD. HOMA-IR = homeostasis model of assessment ratio. TNF-α = tumor necrosis factor alpha. Significant differences 
during the follow-up period are represented by < 0.05*, < 0.01** and < 0.001*** (Wilcoxon signed rank test).
Table 2: Spearman rank correlation between differences (diff) between baseline and follow-up values. R- and (P-values).
Weight diff Waist diff TNF-α diff IL-6 diff Insulin diff Glucose diff
Weight diff - <.0001 -.35 (.0031) .25 (.0312) .27 (.0194) NS
Waist diff - -. 26 (.025) .25 (.0298) .25 (.0298) NS
TNF-α diff - NS -.23 (.045) NS
IL-6 diff - NS NS
Insulin diff - -.27 (.018)
Glucose diff -
TNF-α = tumor necrosis factor alpha. IL-6 = interleukin-6Lindgärde et al. Diabetology & Metabolic Syndrome 2010, 2:38
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Results
Body composition
As can be seen in Table 1 body weight, BMI, waist cir-
cumference, fat mass and fat as a percentage of body
weight increased significantly. Twenty-one of the women
lost body weight (-2.0 ± 1.8 kg) while 52 gained body
weight (+5.6 ± 4.0 kg).
Glucose and insulin
Mean p-glucose increased from 4.12 ± 0.45 to 5.01 ± 1.25
mmol/l (p < 0.001). In contrast p-insulin was unchanged
during the 5 years. Consequently, when calculating insu-
lin resistance according the homeostasis model of assess-
ment ratio, HOMA-IR values increased significantly.
TNF-α and IL-6
The decrease in p-IL-6 from 2.03 ± 2.49 to 1.89 ± 1.50 pg/
ml did not reach significance while the decrease in TNF-
α from 4.43 ± 1.75 to 3.35 ± 3.85 was significant (p =
0.003). In subjects who lost body weight p-TNF-α and p-
IL-6 concentrations were unchanged during the follow-
up period. In women who gained body weight. p-TNF-α
concentration decreased from 4.9 ± 6.7 pg/ml to 3.3 ± 3.9
(p < 0.0001) whereas p-IL-6 increased from 1.75 ± 2.27 to
2.03 ± 1.63 (p = 0.002).
Weight change in relation to differences in waist 
circumference, p-cytokine, insulin and glucose 
concentrations between baseline and follow-up 
examinations
Differences were calculated as the value at follow-up sub-
tracted from the value at baseline. Spearman rank corre-
lation was used to analyse the associations (Table 2).
Weight and waist differences correlated negatively to the
difference in p-TNF-α but positively to differences in p-
IL-6 and p-insulin, whereas the increase of p-glucose
from baseline to follow-up did not correlate with changes
in levels of the two cytokines. The decrease of p-TNF-α
during the observation period correlated negatively to
changes of p-insulin.
Predictors of weight and waist increase
Multiple regression analysis was conducted to sort out
independent contributions of differences in p-IL-6, TNF-
α and insulin during the observation period to the vari-
ance in weight and waist circumference. Both changes of
TNF-α and insulin contributed independently to the vari-
ance in weight (Table 3) and together with p-IL-6 in waist
circumference (Table 4).
Predictors of plasma insulin and glucose values at follow-
up
The multiple regression analysis revealed that weight
change and p-insulin at baseline were the only significant
predictors of fasting p-insulin at follow-up (Table 5). Nei-
ther p-TNF-α nor p-IL-6 and age at baseline, or the varia-
tions of the two cytokines during the observation period
contributed independently to the variance of p-insulin at
follow-up.
In order to sort out whether weight and waist changes
together with baseline measurements were associated
with p-glucose at follow-up, a partial correlation matrix
was studied. The analysis gave the following R values with
p-glucose at follow-up; weight change = - 0.38, waist
change = 0.35, S-16:1n-7 = 0.57, systolic blood pressure =
- 0.38, p-insulin = 0.19, p-TNF-α = -0.04 and p-IL-6 =
0.34.
In a multiple regression analysis including these vari-
ables and age as independent determinants both anthro-
pometric measurements together with S-16:1n-7, SBP
and p-glucose at baseline were significant determinants
and explained 49.0% of the variability (Table 6).When b-
glucose was omitted from this analysis, 45.4% of the vari-
ability was explained by the other factors. P-concentra-
tions of insulin and IL-6 and age did not contribute
independently to the variability of p-glucose measured
five years later.
Discussion
Epidemiological studies have demonstrated that deterio-
rating glucose tolerance is closely associated with
increasing body fat mass and obesity especially in indi-
viduals with an Amerindian heritage [17,18]. In the pres-
ent prospective study of 73 Peruvian Amerindian women
with fasting p-glucose within the normal range, the pro-
portion of palmitoleic acid (16:1n-7) in serum and sys-
tolic blood pressure were strong independent
determinants of higher p-glucose values 5 years after the
baseline examination, and this was seen in association
with unaltered p-insulin [3]. This suggests that insulin
resistance with adequate islet compensation existed at
the time of the first examination [1], whereas after the 5
year period, insulin secretion from β-cells was insuffi-
cient to cope with a further deterioration of peripheral
insulin sensitivity.
Twenty-one of the women lost body weight (-2.0 ± 1.8
kg) while 52 gained body weight (+5.6 ± 4.0 kg). P-TNF-α
and p-IL-6 concentrations were unchanged in women
who lost weight whereas p-TNF-α concentration
decreased (p < 0.0001) and p-IL-6 values increased (P =
0.0002) in women who gained weight during the observa-
tion period. We now report that differences in body
weights and waist circumferences during the observation
period correlated negatively to changes in p-TNF-α and
positively with p-IL-6 values, (Table 2), and that mea-
sured differences in p-TNF-α contributed independently
to the variance in weight (Table 3) and together with
changed p-IL-6 concentrations were determinants of the
variation of waist circumferences that took place duringLindgärde et al. Diabetology & Metabolic Syndrome 2010, 2:38
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the 5 years study period (Table 4). This disassociation
between differences of TNF-α and p-IL-6 in samples
from the baseline and follow-up surveys in relation to
natural variation of body weight and waist is a novel find-
ing. The alteration of body weight, in contrast to change
in waist circumference, together with p-insulin value at
baseline were strong predictors of fasting insulin concen-
tration at the follow-up survey (Table 5). Neither p-TNF-
α nor p-IL-6 at baseline or the variation of the two cytok-
ines during the observation period, on the other hand,
contributed independently to the variance of p-insulin at
follow-up.
In our previous report [3] serum 16:1n-7 was closely
related to a cluster of risk factors associated with the met-
abolic syndrome and an increased risk of glucose intoler-
ance and cardiovascular diseases. A majority of the
participants had higher fasting p-glucose concentrations
at follow-up (86%), but only two had developed diabetes.
This increased glycaemia may represent the first step
towards manifest diabetes as a consequence of primarily
β-cell dysfunction with or without simultaneous increas-
ing insulin resistance [19]. P-glucose concentration in the
population increased during the observation period to
the same degree independently of whether women gained
lost body weight. A multiple regression analysis with p-
glucose concentration at follow-up as dependent variable
revealed disassociation between changes of body weight
and waist in relation to p-glucose concentration at follow-
up (Table 6).
These findings suggest a contributing role for the two
cytokines indirectly to changes in glucose metabolism
through their diametrically opposed influences on weight
and waist.The findings of the present study indicate that
the increase in p-glucose values during the observation
period first of all was related to fatty acid metabolism. In
human obesity 16:1n-7 in serum cholesterol ester
strongly correlates with indexes of adiposity [20]. Also in
the present study, s-16:1n-7 proportion was related to
anthropometric measurements at baseline, such as waist
circumference (P = 0.006), and percentage body fat (P =
0.0003), but not to p-TNF-α and p-IL-6 or to changes in
weight, waist circumference or in levels of the two cytok-
Table 3: Multiple regression with weight, insulin, p-TNF-α and p-IL-6 variables from baseline and differences of TNF-α, IL-6 
and insulin during 5 years as independent variables and body weight change during 5 years as dependent variable.
Coefficient SE P-value Standardized 
coefficient
Intercept 0.03 2.40 0.99 0.03
P-TNF-α difference -0.50 0.21 0.020 -0.40
P-IL-6 difference 0.70 0.36 0.054 0.39
P-insulin difference 0.04 0.01 0.0003 0.41
Weight baseline 0.004 0.04 0.909 0.01
P-insulin baseline 0.03 0.02 0.024 0.27
P-TNF-α baseline -0.17 0.14 0.235 -0.20
P-IL-6 baseline 0.38 0.39 0.338 0.19
Table 4: Multiple regression with waist, insulin, p-TNF-α and p-IL-6 variables from baseline and changes of p-TNF- α, IL-6 
and insulin during 5 years as independent variables and waist circumference change during 5 years as dependent 
variable.
Coefficient SE P-value Standardized 
coefficient
Intercept -0.93 5.63 0.87 -0.93
P-TNF-α difference -0.59 0.24 0.016 -0.43
P-IL-6 difference 1.14 0.41 0.007 0.60
P-insulin difference 0.02 0.01 0.025 0.26
Waist baseline -0.05 0.05 0.15 0.18
P-insulin baseline 0.02 0.02 0.021 0.29
P-TNF-α baseline -0.16 0.16 0.316 -0.18
P-IL-6 baseline 0.71 0.45 0.117 0.34Lindgärde et al. Diabetology & Metabolic Syndrome 2010, 2:38
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ines. Thus, in addition to the close association between s-
16:1n-7 and deterioration of fasting glucose concentra-
tion, changes in body weight and waist circumference
were also determinants of p-glucose at follow-up.
The intimate relationship between visceral obesity and
inflammation was underscored by the findings that inten-
t i o n a l  w e i g h t  r e d u c t i o n  c a u s e s  d o w n  r e g u l a t i o n  o f
inflammation in visceral fat as well in the circulation [21-
23]. This was in the present study illustrated by the fact
that p-TNF-α and IL-6 concentrations were unchanged in
subjects who lost body weight. However, at the same time
waist circumferences increased significantly, whereas the
percentage of body fat was unchanged (data not shown).
Taken together, these findings indicate that lean body
mass has to some extent decreased and subcutaneous
body fat has been redistributed.
Our study population is characterized by a sedentary
lifestyle and low cardiorespiratory fitness [2]. It is most
likely that the increases of body weight and waist circum-
ference during the 5 years were due to reduced energy
expenditure. The mechanism of energy expenditure
i n v o l v e s  i n fl a m m a t o ry  cyt o ki n e s,  s u c h  as  T NF - α ,  IL - 1 ,
and IL-6, levels of which are positively associated with
energy expenditure [24]. In transgenic mice with defi-
ciencies in these cytokines or their receptors, body
weight gain is enhanced [25]. In contrast, when cytokine
activity is stimulated, energy expenditure is increased,
and body weight gain is attenuated [26,27]. Thus, the
reduction of p-TNF-α and the concomitant weight gain in
our study group is in line with these observations. Inflam-
mation may have two different roles in the regulation of
metabolism. The first may be inhibition of insulin sensi-
tivity (a negative effect), as suggested by many studies of
low grade inflammation [28-30], and the second may be
induction of energy expenditure (a positive effect)
[27,31].
A strength of our study is that we followed a homoge-
nous group of women with normal p-glucose values and
Table 5: Multiple regression with p-TNF-α, IL-6 and insulin at baseline together with changes of weight, waist, p-TNF-α, IL-
6 and insulin as independent variables and p-insulin at follow-up as dependent variable.
Coefficient SE P-value Standardized 
coefficient
Intercept 0.71 0.22 0.002 0.71
P-TNF-α difference -0.06 0.09 0.55 -0.07
P-IL-6 difference 0.11 0.07 0.10 0.22
Weight difference 0.02 0.01 0.0006 0.53
Waist difference -0.01 0.01 0.13 -0.21
P-insulin baseline 0.62 0.11 < 0.0001 0.55
P-TNF-α baseline 0.04 0.07 0.60 0.06
P-IL-6 baseline -0.03 0.07 0.72 -0.05
Age -0.01 0.01 0.84 -0.02
Table 6: Multiple regression with changes of weight and waist together with baseline values of the proportion of 
palmitoleic acid (16:1n-7) in serum, systolic blood pressure (SBP), plasma (p-) concentrations of glucose, IL-6 and insulin as 
independent variables and p-glucose at follow-up as dependent variable.
Coefficient SE P-value Standardized 
coefficient
Intercept 0.99 0.22 < 0.001 0.99
Weight change - 0.01 0.002 0.007 -0.43
Waist change 0.01 0.002 0.0125 0.38
S-16:l-n7 baseline 0.34 0.07 < 0.0001 0.54
SBP baseline -0.43 0.19 0.0005 -0.41
P-glucose baseline 0.37 0.18 0.044 0.23
P-insulin baseline 0.07 0.04 0.086 0.19
P-IL-6 baseline 0.02 0.02 0.175 0.13
Age 0.01 0.001 0.74 -0.04Lindgärde et al. Diabetology & Metabolic Syndrome 2010, 2:38
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hyperinsulinaemia [1] for a relatively long period of time,
5 years [3]. Another strength of the study is that no active
intervention (diet or exercise programmes) took place
since all women had normal fasting p-glucose concentra-
tion at the baseline survey. Accordingly it was possible to
examine relationships between circulating TNF-α, IL-6,
insulin and glucose taking the natural variation of body
weight into account.
It is well known that advancing age plays an important
role in the progressive β-cell failure that characterises
type 2 diabetes. However, age did not correlate with any
measured variable at baseline and was not a determinant
of p-insulin (table 5) or p-glucose (table 6) at follow-up.
These observations indicate that age in the present study
may not explain the increase of insulin resistance (table 1)
during the 5-year observation period.
The report by Chan et al [32] is in agreement with our
observations They found that obesity, dyslipidemia, IL-6,
and TNF-α were the principal explanatory variables for
the various components of the metabolic syndrome in
Caucasian non-diabetic subjects, with IL-6 and TNF-α
having different explanatory variables and effects [32].
Our findings of disassociations between p-TNF-α and p-
IL-6 in relation to changes of body weight and waist cir-
cumference are thus partly consistent with previous work
and would suggest an importance for these cytokines also
in this population of Amerindian women.
Conclusions
The present prospective study revealed disassociation
between the changes in p-TNF-α and p-IL-6 concentra-
tions in samples from the baseline survey and the follow-
up measurements in relation to body weight at follow-up
five years later when natural variation of body weight was
taken into account. The exact role of the opposite effects
and clinical impact of p-TNF-α and p-IL-6 on develop-
ment of insulin resistance and perhaps type 2 diabetes in
subjects with unintentional wasting and women who
gained body weight now needs to be examined further.
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